Opus Genetics's market cap is currently $98.25M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Opus Genetics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
